For startup CEOs, there’s probably nothing more nerve wracking than giving a presentation to prospective investors. Dr. Lisa Beth Ferstenberg knows about that first-hand.
A serial biotech entrepreneur, Ferstenberg was founding CEO of Cellective Therapeutics, a Gaithersburg biotech that raised $28 million in Series A funding. MedImmune bought the company in 2005 for as much as $160 million. She is currently chief medical officer for Sequella Inc., a Rockville biotech that develops drugs to fight tuberculosis.